NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has raised a $130 million Series B led by Kleiner Perkins. New investors Nat Friedman, Daniel Gross, and Khosla Ventures also invested, as did returning backers Founders Fund,…
NewLimit, founded by Coinbase CEO Brian Armstrong, raises $130M to develop age-reversing treatments – News – Ceacer Nulled
$0.00
Reviews
There are no reviews yet.